Experimental murine amyloidosis: a model system for studying amyloid formation

Area of Science:

• Immunology
• Pathology
• Biochemistry

Background:

• Amyloidosis is characterized by the deposition of insoluble protein aggregates in tissues.
• Murine models, including myeloma-associated and casein-induced amyloidosis, are crucial for studying amyloid pathogenesis.
• The roles of lymphocytes and macrophages in amyloid formation require further elucidation.

Purpose of the Study:

• To investigate the involvement of lymphocytes and macrophages in the pathogenesis of myeloma-associated and casein-induced murine amyloidosis.
• To differentiate between immunoglobulin (Ig)-dependent and Ig-independent amyloid formation pathways.
• To identify the cellular source of non-Ig amyloid deposits.

Main Methods:

• Induction of amyloidosis in Balb/C mice using myeloma tumors and casein injections.
• Fluorescent staining of amyloid deposits using specific antibodies (anti-casein and anti-myeloma amyloid).
• Assessment of immunoglobulin biosynthesis and cellular immunologic responses in spleen lymphocytes.

Main Results:

• Amyloidosis occurred in small amounts with myeloma tumors but in large amounts with casein injections.
• Fluorescent staining suggested cross-reactivity or coexistence of casein and myeloma amyloid.
• No abnormalities in Ig biosynthesis were detected; abnormal degradation was implicated in Ig-amyloid production.
• Macrophages were identified as the producers of the non-Ig form of amyloid in casein-injected mice.
• Diminished, but not generalized, immunologic incompetence was observed in spleen lymphocytes of affected mice.
• A technique to increase the yield of amyloid-containing cells was developed.

Conclusions:

• Macrophage involvement is critical in the non-immunoglobulin form of amyloidosis.
• Abnormal protein degradation, rather than aberrant biosynthesis, likely leads to immunoglobulin-based amyloid formation.
• Murine models provide valuable insights into the cellular mechanisms underlying different types of amyloidosis.